Advanced specialty test to evaluate common genetic variations that may indicate predisposition to diseases
Genomic testing evaluates common genetic variations (known as single nucleotide polymorphisms, or SNPs) that may indicate vulnerabilities or predisposition to certain diseases. Different functional areas may be assessed for SNPs, such as cardiovascular, detoxification, immune modulation, methylation, and estrogen metabolism.
What we can measure:
The Genovations® product line offers genomic testing to evaluate common genetic variations known as single nucleotide polymorphisms (SNPs). The presence of specific SNPs may indicate a predisposition for health vulnerabilities. SNPS may be assessed in multiple functional areas including cardiovascular, detoxification, methylation, immune modulation, and estrogen metabolism.